International Registry and Clinical Study for Wolfram Syndrome and Related WFS1 Disorders Tracking Disease Progression and Genetic Insights

What this Trial Is About

Researchers are studying Wolfram syndrome, a rare genetic disorder that causes juvenile diabetes, optic nerve damage, and progressive neurological problems. The study aims to understand this disease better by creating and maintaining an international registry of patients. This registry collects detailed clinical information to define the natural history of Wolfram syndrome and investigates its genetic causes and related metabolic traits. The research may also provide insights into more common forms of diabetes and neurodegeneration. The study uses an internet-based registry to enroll patients diagnosed with Wolfram syndrome based on specific clinical and genetic criteria. Participants may provide blood and urine samples up to three times a year for genetic testing and biomarker analysis. They will also complete an electronic questionnaire to assess their activity levels and quality of life. Optionally, some participants may have cells collected to create stem cells for future research. The registry supports collaboration among international researchers and may connect participants to other Wolfram syndrome-related clinical trials. Participants contribute data through online questionnaires and provide biological samples for testing. The study monitors various biomarkers, including C-peptide levels, to track disease progression over time. Researchers also assess vision changes using standard eye tests. The study aims to gather comprehensive data over many years to improve understanding and guide future treatments. Participation involves regular follow-up and contributes to a global effort to advance knowledge of Wolfram syndrome and related disorders.

Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study